Gossamer Bio Inc. (GOSS) Tops Q2 EPS by 4c

Gossamer Bio Inc. (NASDAQ: GOSS) reported Q2 EPS of ($0.45), $0.04 better than the analyst estimate of ($0.49).

For earnings history and earnings-related data on Gossamer Bio Inc. (GOSS) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• Deutsche Bank Upgrades Danone SA (BN:FP) (DANOY) to Hold
• Jefferies Starts DBS Group Holdings (DBS:SP) (DBSDY) at Buy